Obesity drug may cure chocolate cravings

Mar 20, 2008

Researchers in Italy said the anti-obesity drug rimonabant may help chocoholics end their addiction.

Giancarlo Colombo of the Institute of Neuroscience in Cagliari said mice given a chocolate drip consumed more than a tenth of their body weight in 20 minutes until they were given a dose of rimonabant, ANSA reported Wednesday.

Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. In Europe, it is indicated for use in patients with a body mass index greater than 30 or those with risk factors such as type 2 diabetes or dyslipidemia, ANSA said.

Copyright 2008 by United Press International

Explore further: Chile government rejects 14 year-old's plea for euthanasia

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Many transplant surgeons suffer burnout

Feb 25, 2015

Despite saving thousands of lives yearly, nearly half of organ transplant surgeons report a low sense of personal accomplishment and 40% feel emotionally exhausted, according to a national study on transplant surgeon burnout

5 tips for handling early-year medical expenses

Feb 25, 2015

The clock on insurance deductibles reset on Jan. 1, and that means big medical bills are in store for some. Patients may be required to pay thousands of dollars before their health care coverage kicks in.

User comments : 2

Adjust slider to filter visible comments by rank

Display comments: newest first

AJW
not rated yet Mar 20, 2008
Was that milk chocolate? or dark?
or white?
What did the mice do with their
extra time now that they are not
eating chocolate?
TheRogue
not rated yet Mar 20, 2008
Why would any sane person wish to lose their cravings for chocolate? Dark chocolate is especially healthy if one simply learns to stay away from heavily sugared chocolate as most are.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.